Bloomberg Businessweek cover image

Lilly’s Zepbound Cut Risk of Diabetes by 94% in Obese People

Bloomberg Businessweek

00:00

Exploring Weight Loss Drugs and Their Long-Term Health Implications

This chapter explores the impacts of weight loss medications on health, focusing on type 2 diabetes and obesity-related conditions. It considers recent findings on their effectiveness, the implications of long-term use, and the interplay of economic factors and treatment combinations for optimal patient outcomes.

Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner